1 Introduction to Research & Analysis Reports
1.1 Pertussis Vaccination Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pertussis Vaccination Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Pertussis Vaccination Overall Market Size
2.1 Global Pertussis Vaccination Market Size: 2022 VS 2029
2.2 Global Pertussis Vaccination Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Pertussis Vaccination Sales: 2018-2029
3 Company Landscape
3.1 Top Pertussis Vaccination Players in Global Market
3.2 Top Global Pertussis Vaccination Companies Ranked by Revenue
3.3 Global Pertussis Vaccination Revenue by Companies
3.4 Global Pertussis Vaccination Sales by Companies
3.5 Global Pertussis Vaccination Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Pertussis Vaccination Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Pertussis Vaccination Product Type
3.8 Tier 1, Tier 2 and Tier 3 Pertussis Vaccination Players in Global Market
3.8.1 List of Global Tier 1 Pertussis Vaccination Companies
3.8.2 List of Global Tier 2 and Tier 3 Pertussis Vaccination Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Pertussis Vaccination Market Size Markets, 2022 & 2029
4.1.2 Acellular Vaccines
4.1.3 Whole-cell Vaccines
4.2 By Type – Global Pertussis Vaccination Revenue & Forecasts
4.2.1 By Type – Global Pertussis Vaccination Revenue, 2018-2023
4.2.2 By Type – Global Pertussis Vaccination Revenue, 2024-2029
4.2.3 By Type – Global Pertussis Vaccination Revenue Market Share, 2018-2029
4.3 By Type – Global Pertussis Vaccination Sales & Forecasts
4.3.1 By Type – Global Pertussis Vaccination Sales, 2018-2023
4.3.2 By Type – Global Pertussis Vaccination Sales, 2024-2029
4.3.3 By Type – Global Pertussis Vaccination Sales Market Share, 2018-2029
4.4 By Type – Global Pertussis Vaccination Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Pertussis Vaccination Market Size, 2022 & 2029
5.1.2 12 Months Below
5.1.3 12 Months Above
5.2 By Application – Global Pertussis Vaccination Revenue & Forecasts
5.2.1 By Application – Global Pertussis Vaccination Revenue, 2018-2023
5.2.2 By Application – Global Pertussis Vaccination Revenue, 2024-2029
5.2.3 By Application – Global Pertussis Vaccination Revenue Market Share, 2018-2029
5.3 By Application – Global Pertussis Vaccination Sales & Forecasts
5.3.1 By Application – Global Pertussis Vaccination Sales, 2018-2023
5.3.2 By Application – Global Pertussis Vaccination Sales, 2024-2029
5.3.3 By Application – Global Pertussis Vaccination Sales Market Share, 2018-2029
5.4 By Application – Global Pertussis Vaccination Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Pertussis Vaccination Market Size, 2022 & 2029
6.2 By Region – Global Pertussis Vaccination Revenue & Forecasts
6.2.1 By Region – Global Pertussis Vaccination Revenue, 2018-2023
6.2.2 By Region – Global Pertussis Vaccination Revenue, 2024-2029
6.2.3 By Region – Global Pertussis Vaccination Revenue Market Share, 2018-2029
6.3 By Region – Global Pertussis Vaccination Sales & Forecasts
6.3.1 By Region – Global Pertussis Vaccination Sales, 2018-2023
6.3.2 By Region – Global Pertussis Vaccination Sales, 2024-2029
6.3.3 By Region – Global Pertussis Vaccination Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Pertussis Vaccination Revenue, 2018-2029
6.4.2 By Country – North America Pertussis Vaccination Sales, 2018-2029
6.4.3 US Pertussis Vaccination Market Size, 2018-2029
6.4.4 Canada Pertussis Vaccination Market Size, 2018-2029
6.4.5 Mexico Pertussis Vaccination Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Pertussis Vaccination Revenue, 2018-2029
6.5.2 By Country – Europe Pertussis Vaccination Sales, 2018-2029
6.5.3 Germany Pertussis Vaccination Market Size, 2018-2029
6.5.4 France Pertussis Vaccination Market Size, 2018-2029
6.5.5 U.K. Pertussis Vaccination Market Size, 2018-2029
6.5.6 Italy Pertussis Vaccination Market Size, 2018-2029
6.5.7 Russia Pertussis Vaccination Market Size, 2018-2029
6.5.8 Nordic Countries Pertussis Vaccination Market Size, 2018-2029
6.5.9 Benelux Pertussis Vaccination Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Pertussis Vaccination Revenue, 2018-2029
6.6.2 By Region – Asia Pertussis Vaccination Sales, 2018-2029
6.6.3 China Pertussis Vaccination Market Size, 2018-2029
6.6.4 Japan Pertussis Vaccination Market Size, 2018-2029
6.6.5 South Korea Pertussis Vaccination Market Size, 2018-2029
6.6.6 Southeast Asia Pertussis Vaccination Market Size, 2018-2029
6.6.7 India Pertussis Vaccination Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Pertussis Vaccination Revenue, 2018-2029
6.7.2 By Country – South America Pertussis Vaccination Sales, 2018-2029
6.7.3 Brazil Pertussis Vaccination Market Size, 2018-2029
6.7.4 Argentina Pertussis Vaccination Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Pertussis Vaccination Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Pertussis Vaccination Sales, 2018-2029
6.8.3 Turkey Pertussis Vaccination Market Size, 2018-2029
6.8.4 Israel Pertussis Vaccination Market Size, 2018-2029
6.8.5 Saudi Arabia Pertussis Vaccination Market Size, 2018-2029
6.8.6 UAE Pertussis Vaccination Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Sanofi Pasteur
7.1.1 Sanofi Pasteur Company Summary
7.1.2 Sanofi Pasteur Business Overview
7.1.3 Sanofi Pasteur Pertussis Vaccination Major Product Offerings
7.1.4 Sanofi Pasteur Pertussis Vaccination Sales and Revenue in Global (2018-2023)
7.1.5 Sanofi Pasteur Key News & Latest Developments
7.2 GSK
7.2.1 GSK Company Summary
7.2.2 GSK Business Overview
7.2.3 GSK Pertussis Vaccination Major Product Offerings
7.2.4 GSK Pertussis Vaccination Sales and Revenue in Global (2018-2023)
7.2.5 GSK Key News & Latest Developments
7.3 Mitsubishi Tanabe Pharma
7.3.1 Mitsubishi Tanabe Pharma Company Summary
7.3.2 Mitsubishi Tanabe Pharma Business Overview
7.3.3 Mitsubishi Tanabe Pharma Pertussis Vaccination Major Product Offerings
7.3.4 Mitsubishi Tanabe Pharma Pertussis Vaccination Sales and Revenue in Global (2018-2023)
7.3.5 Mitsubishi Tanabe Pharma Key News & Latest Developments
7.4 KM Biologics
7.4.1 KM Biologics Company Summary
7.4.2 KM Biologics Business Overview
7.4.3 KM Biologics Pertussis Vaccination Major Product Offerings
7.4.4 KM Biologics Pertussis Vaccination Sales and Revenue in Global (2018-2023)
7.4.5 KM Biologics Key News & Latest Developments
7.5 Wuhan Institute of Biological Products
7.5.1 Wuhan Institute of Biological Products Company Summary
7.5.2 Wuhan Institute of Biological Products Business Overview
7.5.3 Wuhan Institute of Biological Products Pertussis Vaccination Major Product Offerings
7.5.4 Wuhan Institute of Biological Products Pertussis Vaccination Sales and Revenue in Global (2018-2023)
7.5.5 Wuhan Institute of Biological Products Key News & Latest Developments
7.6 Walvax Biotechnology
7.6.1 Walvax Biotechnology Company Summary
7.6.2 Walvax Biotechnology Business Overview
7.6.3 Walvax Biotechnology Pertussis Vaccination Major Product Offerings
7.6.4 Walvax Biotechnology Pertussis Vaccination Sales and Revenue in Global (2018-2023)
7.6.5 Walvax Biotechnology Key News & Latest Developments
7.7 Chengdu Institute of Biological Products
7.7.1 Chengdu Institute of Biological Products Company Summary
7.7.2 Chengdu Institute of Biological Products Business Overview
7.7.3 Chengdu Institute of Biological Products Pertussis Vaccination Major Product Offerings
7.7.4 Chengdu Institute of Biological Products Pertussis Vaccination Sales and Revenue in Global (2018-2023)
7.7.5 Chengdu Institute of Biological Products Key News & Latest Developments
7.8 Minhai Biotechnology
7.8.1 Minhai Biotechnology Company Summary
7.8.2 Minhai Biotechnology Business Overview
7.8.3 Minhai Biotechnology Pertussis Vaccination Major Product Offerings
7.8.4 Minhai Biotechnology Pertussis Vaccination Sales and Revenue in Global (2018-2023)
7.8.5 Minhai Biotechnology Key News & Latest Developments
8 Global Pertussis Vaccination Production Capacity, Analysis
8.1 Global Pertussis Vaccination Production Capacity, 2018-2029
8.2 Pertussis Vaccination Production Capacity of Key Manufacturers in Global Market
8.3 Global Pertussis Vaccination Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Pertussis Vaccination Supply Chain Analysis
10.1 Pertussis Vaccination Industry Value Chain
10.2 Pertussis Vaccination Upstream Market
10.3 Pertussis Vaccination Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Pertussis Vaccination Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
世界の百日咳ワクチン接種市場予測2023-2029：無細胞ワクチン、全細胞ワクチン |
| 【英語タイトル】Pertussis Vaccination Market, Global Outlook and Forecast 2023-2029 | |
 | ・商品コード：MMG23JU5892 ・発行会社（調査会社）：Market Monitor Global ・発行日：2023年6月 ・ページ数：76 ・レポート言語：英語 ・レポート形式：PDF ・納品方法：Eメール（受注後2-3営業日） ・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど ・産業分野：医薬品＆医療 |
| Single User（1名様閲覧用） | USD3,250 ⇒換算￥494,000 | 見積依頼/購入/質問フォーム |
| Multi User（20名様閲覧用） | USD4,225 ⇒換算￥642,200 | 見積依頼/購入/質問フォーム |
| Enterprise User（閲覧人数制限なし） | USD4,875 ⇒換算￥741,000 | 見積依頼/購入/質問フォーム |
|
※販売価格オプションの説明 ※お支払金額：換算金額（日本円）＋消費税 ※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡） ※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能） |
| 当調査レポートは次の情報を含め、世界の百日咳ワクチン接種市場規模と予測を収録しています。・世界の百日咳ワクチン接種市場：売上、2018年-2023年、2024年-2029年 ・世界の百日咳ワクチン接種市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の百日咳ワクチン接種市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「無細胞ワクチン」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 百日咳ワクチン接種のグローバル主要企業は、Sanofi Pasteur、 GSK、 Mitsubishi Tanabe Pharma、 KM Biologics、 Wuhan Institute of Biological Products、 Walvax Biotechnology、 Chengdu Institute of Biological Products、 Minhai Biotechnologyなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、百日咳ワクチン接種のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の百日咳ワクチン接種市場：タイプ別、2018年-2023年、2024年-2029年 世界の百日咳ワクチン接種市場：タイプ別市場シェア、2022年 ・無細胞ワクチン、全細胞ワクチン 世界の百日咳ワクチン接種市場：用途別、2018年-2023年、2024年-2029年 世界の百日咳ワクチン接種市場：用途別市場シェア、2022年 ・12ヶ月以下、12ヶ月以上 世界の百日咳ワクチン接種市場：地域・国別、2018年-2023年、2024年-2029年 世界の百日咳ワクチン接種市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における百日咳ワクチン接種のグローバル売上、2018年-2023年 ・主要企業における百日咳ワクチン接種のグローバル売上シェア、2022年 ・主要企業における百日咳ワクチン接種のグローバル販売量、2018年-2023年 ・主要企業における百日咳ワクチン接種のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Sanofi Pasteur、 GSK、 Mitsubishi Tanabe Pharma、 KM Biologics、 Wuhan Institute of Biological Products、 Walvax Biotechnology、 Chengdu Institute of Biological Products、 Minhai Biotechnology ************************************************************* ・調査・分析レポートの概要 百日咳ワクチン接種市場の定義 市場セグメント 世界の百日咳ワクチン接種市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の百日咳ワクチン接種市場規模 世界の百日咳ワクチン接種市場規模：2022年 VS 2029年 世界の百日咳ワクチン接種市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの百日咳ワクチン接種の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の百日咳ワクチン接種製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：無細胞ワクチン、全細胞ワクチン 百日咳ワクチン接種のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：12ヶ月以下、12ヶ月以上 百日咳ワクチン接種の用途別グローバル売上・予測 ・地域別市場分析 地域別百日咳ワクチン接種市場規模 2022年と2029年 地域別百日咳ワクチン接種売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Sanofi Pasteur、 GSK、 Mitsubishi Tanabe Pharma、 KM Biologics、 Wuhan Institute of Biological Products、 Walvax Biotechnology、 Chengdu Institute of Biological Products、 Minhai Biotechnology ... |
Pertussis vaccine is a vaccine that protects against whooping cough. There are two main types: whole-cell vaccines and acellular vaccines. The whole-cell vaccine is about 78% effective while the acellular vaccine is 71–85% effective.
This report aims to provide a comprehensive presentation of the global market for Pertussis Vaccination, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pertussis Vaccination. This report contains market size and forecasts of Pertussis Vaccination in global, including the following market information:
Global Pertussis Vaccination Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Pertussis Vaccination Market Sales, 2018-2023, 2024-2029, (Units)
Global top five Pertussis Vaccination companies in 2022 (%)
The global Pertussis Vaccination market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Acellular Vaccines Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Pertussis Vaccination include Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, KM Biologics, Wuhan Institute of Biological Products, Walvax Biotechnology, Chengdu Institute of Biological Products and Minhai Biotechnology, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pertussis Vaccination manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pertussis Vaccination Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Pertussis Vaccination Market Segment Percentages, by Type, 2022 (%)
Acellular Vaccines
Whole-cell Vaccines
Global Pertussis Vaccination Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Pertussis Vaccination Market Segment Percentages, by Application, 2022 (%)
12 Months Below
12 Months Above
Global Pertussis Vaccination Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Pertussis Vaccination Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pertussis Vaccination revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Pertussis Vaccination revenues share in global market, 2022 (%)
Key companies Pertussis Vaccination sales in global market, 2018-2023 (Estimated), (Units)
Key companies Pertussis Vaccination sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi Pasteur
GSK
Mitsubishi Tanabe Pharma
KM Biologics
Wuhan Institute of Biological Products
Walvax Biotechnology
Chengdu Institute of Biological Products
Minhai Biotechnology
Outline of Major Chapters:
Chapter 1: Introduces the definition of Pertussis Vaccination, market overview.
Chapter 2: Global Pertussis Vaccination market size in revenue and volume.
Chapter 3: Detailed analysis of Pertussis Vaccination manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pertussis Vaccination in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Pertussis Vaccination capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
❖ レポートの目次 ❖
| ★調査レポート[世界の百日咳ワクチン接種市場予測2023-2029：無細胞ワクチン、全細胞ワクチン] (コード：MMG23JU5892)販売に関する免責事項を必ずご確認ください。 |
| ★調査レポート[世界の百日咳ワクチン接種市場予測2023-2029：無細胞ワクチン、全細胞ワクチン]についてメールでお問い合わせ |
